Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
'Do the right thing': Billionaire pushes struggling biotech to return cash to investors
3 years ago
Drug R&D hurdles hamper another biotech as a Jeff Aronin upstart shuts down
3 years ago
Startups
Surface Oncology lays off 20% as biotech halts CD39 work on one of its ‘crown jewels’
3 years ago
R&D
After months of back and forth, Mereo and its biggest stockholder reach truce, replace board members
3 years ago
Pharma
Plant-based Covid-19 vaccine developer Medicago laying off 60+ at North Carolina plant
3 years ago
R&D
Glyn Edwards takes chairman role at UK oncolytic virus startup emerging out of stealth
3 years ago
Startups
GSK CEO Emma Walmsley triggers executive team revamp as vaccines chief Connor exits
3 years ago
Pharma
Ex-Genentech scientist sentenced to six months in prison for stealing trade secrets
3 years ago
Pharma
Law
The namesake behind Harvard’s Wyss Institute has made his fourth donation, this time to the tune of $350M
3 years ago
Financing
R&D
J&J plans to cut 64 jobs at New York plant in new year
3 years ago
Pharma
Updated: A New Jersey biotech shuffles C-suite, halts promotion of yeast infection drug and lays off employees
3 years ago
R&D
Biotech layoffs continue as Ambrx cuts staff and part of its pipeline to extend its cash
3 years ago
R&D
NeuBase lays off 60% of employees as it swaps out antisense focus for gene editing tech endorsed by George Church
3 years ago
Former Tillman Gerngross Covid-19 antibody startup cuts costs and headcount again, one month after rebrand
3 years ago
New-look Fred Hutch snags slice of Bezos fortune for 10 years of research
3 years ago
Financing
Cell/Gene Tx
Despite $109M influx in August, GreenLight Biosciences brings out the axe to chop a quarter of its staff
3 years ago
R&D
Manufacturing
AstraZeneca and GSK settle talent feud in court — again
3 years ago
Pharma
Another biotech CEO departs, leaving behind few employees for PhIII
3 years ago
BIO chief McMurry-Heath on leave as storm clouds gather over group’s direction, legislative setback
3 years ago
FDA+
Under the weight of a 2-year clinical hold, a biotech’s new board starts company review, ousts CEO
3 years ago
Mathai Mammen emerges as top candidate for Biogen CEO job — STAT
3 years ago
BioMarin lays off 120 staffers to 'simplify' the company while FDA reviews its big gene therapy
3 years ago
Ironwood's former pipeline spinout hits another speed bump, laying off 45% and turning toward the mitochondria
3 years ago
R&D
After presiding over stormy years, John McHutchison picks his 'strategic partner' to run Assembly Bio
3 years ago
First page
Previous page
36
37
38
39
40
41
42
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit